Zerodol PG 200/75 mg Tablet

Zerodol PG 200/75 mg Tablet is a pain relieving medicine which is a combination of Aceclofenac (200mg) and Pregabalin (75mg). It is prescribed to treat neuropathic pain. By working on the brain, it reduces a sense of pain by calming damaged or hyperactive nerves.

In this way, it improves your mood and reduces fatigue that the pain might be causing. It should be taken in dose and duration as advice by the doctor. Don't take more than the recommended dose.​

• Treatment of Neuropathic pain
• Pain relief

Zerodol PG 200/75 mg Tablet can cause multiple side effects, most of which are mild to moderate and often temporary. Patients are advised to inform their healthcare provider immediately if symptoms stays for prolonged period of time.

• Nausea
• Vomiting
• Indigestion
• Stomach pain
• Diarrhea
• Loss of appetite
• Heartburn
• Dryness in mouth
• Dizziness
• Sleepiness
• Tiredness
• Uncoordinated body movements

• Doctor determines the exact dose and duration with Zerodol PG 200/75 mg Tablet as per the overall health condition of the patient. This tablet should be taken with food or after food, but at the fix time every day to get effective results.
• Don't miss a dose or overdose on the medicine. Swallow it as a whole with a glass of water and do not crush, chew, or open it.​​
  

• Zerodol PG 200/75 mg Tablet is a pain relieving medicine which is a combination of Aceclofenac (200mg) and Pregabalin (75mg). Aceclofenac is a non-steroidal anti-inflammatory medicine (NSAID) that reduces fever, discomfort, and inflammation (redness and swelling) by inhibiting the production of certain chemical messengers.
• Pregabalin is an alpha 2 delta ligand that helps to minimize pain through changing the activation of calcium channels in nerve cells.​
  

• Brogden, R. N., & Wiseman, L. R. (1996). Aceclofenac: a review of its pharmacodynamic properties and therapeutic potential in the treatment of rheumatic disorders and in pain management. Drugs, 52(1), 113-124. https://pubmed.ncbi.nlm.nih.gov/8799688/
• Rai, A. S., Khan, J. S., Dhaliwal, J., Busse, J. W., Choi, S., Devereaux, P. J., & Clarke, H. (2017). Preoperative pregabalin or gabapentin for acute and chronic postoperative pain among patients undergoing breast cancer surgery: a systematic review and meta-analysis of randomized controlled trials. Journal of Plastic, Reconstructive & Aesthetic Surgery, 70(10), 1317-1328. https://pubmed.ncbi.nlm.nih.gov/28751024/
• Abhimanyu, V., & Richa, T. (2023). Pregabalin Dependence and Management in a 55-Year-Old Female with Chronic Low Back Pain. Cureus, 15(8). https://pmc.ncbi.nlm.nih.gov/articles/PMC10518057/
• Filatova, E. S., Alekseeva, L. I., Taskina, E. A., Kashevarova, N. G., Sharapova, E. P., & Lila, A. M. (2020). Efficacy and safety of combination therapy with aceclofenac and pregabalin, compared with aceclofenac monotherapy for chronic pain in patients with osteoarthritis of the knee joints. Pharmateca, 27(13), 101-107.
• Gelani, H. D., Chauhan, P. P., & Shah, S. K. (2014). Practical Implication of Chromatographic Method for Estimation of Aceclofenac and Pregabalin in Bulk and Pharmaceutical Dosage Forms. Chromatography Research International, 2014(1), 643027.